Open access
Oct 2026
Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer.
A critical role is revealed for MMGT1 in shaping the TNBC immune microenvironment and targeting MMGT1 represents a promising strategy to improve anti-PD-1 immunotherapy outcomes, suggesting that targeting MMGT1 represents a promising strategy to improve anti-PD-1 immunotherapy outcomes.
Shao-Qing Liu, Hong-Bing Liu, Meng-Ying Zhang et al.
· Cell Reports Medicine · 0 citations